Salbutamol clinical trials
Salbutamol is named as an intervention in 5 current clinical trials in our Canada, China, Poland and Turkey registers. 2 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is University of British Columbia (2). The most-studied condition is Paroxysmal Atrial Fibrillation. The EU clinical trials register (CTIS) separately lists 4 authorised or ongoing trials.
Where Salbutamol is approved
All regulators →Of the three regulators tracked here, the first to approve Salbutamol was Canada, on 25 Jan 1994.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Salbutamol
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Salbutamol works
All drug targets →- Beta-2 adrenergic receptor agonist AgonistTarget: ADRB2 adrenoceptor beta 2✓ In ChEMBL and the Guide to Pharmacology
- Abdominal painPhase 3
- Riley-Day syndromePhase 3
- WheezingPhase 3
- Persistent fetal circulation syndromePhase 3
- Pulmonary arterial hypertensionPhase 3
- Pulmonary hypertensionPhase 3
- Pulmonary hypertension, neonatalPhase 3
- Congestive heart failurePhase 2/3
- Myasthenia gravisPhase 2/3
- Pulmonary edemaPhase 2/3
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL714, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 558, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Salbutamol
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- IEIreland: 13 products on the HPRA listEach product record links to the HPRA, which publishes the leaflet and SmPC.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Salbutamol
- ChEMBL
- CHEMBL714
- DrugBank
- DB01001
- PubChem CID
- 2083
- CAS number
- 18559-94-9
- FDA UNII
- QF8SVZ843E
- Wikidata
- Q93346928
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Salbutamol
5 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Salbutamol in the EU trials register (CTIS)
4 trialsAuthorised or ongoing trials in the EU Clinical Trials Information System that list a product containing Salbutamol. Many trials are registered in both CTIS and ClinicalTrials.gov, so these are shown separately rather than added to the count above. Trials with a site in Ireland are listed first.
Salbutamol across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Licensed in Ireland (HPRA)
13 single-substance products containing Salbutamol on the HPRA medicines list.
- Salamol CFC-Free Inhaler 100 micrograms pressurised inhalation, suspensionNorton Waterford · PA0436/032/001 · Marketed
- Salamol Easi-Breathe CFC-Free Inhaler 100 micrograms Pressurised Inhalation, SuspensionNorton Waterford · PA0436/032/002 · Marketed
- Salamol Steri-Neb 2.5 mg/2.5 ml nebuliser solutionTeva B.V. · PA1986/086/001 · Marketed
- Salamol Steri-Neb 5 mg/2.5 ml Nebuliser SolutionTeva B.V. · PA1986/086/002 · Marketed
- Ventolin 1mg/ml Concentrate for Solution for Intravenous InfusionGlaxoSmithKline (Ireland) Limited · PA1077/049/002 · Marketed
Supply shortages
- Salbutamol inhalation productsEU (EMA) · Shortage resolved · first published 5 Jun 2024
- Bronchospray AutohalerGermany (BfArM) · Other reason · 16 Jan 2026 to 1 Feb 2027
- Cyclocaps Salbutamol 400 µgGermany (BfArM) · Other reason · 1 Aug 2025 to 31 Dec 2026
Conditions studied with Salbutamol
10 conditionsSponsors
lead sponsor per trialBy country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Canada | 2 | 1 |
| Clinical trials in China | 1 | 1 |
| Clinical trials in Poland | 1 | 0 |
| Clinical trials in Turkey | 1 | 0 |
| EU register (CTIS) | 4 | — |
A trial with sites in more than one country appears in each of those registers. CTIS does not publish a recruiting flag; its trials may also appear in the registers above.
Related compounds
Questions about Salbutamol trials
How many clinical trials are testing Salbutamol?
5 current trials in our Canada, China, Poland and Turkey registers name Salbutamol as a drug or biological intervention, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.
Are Salbutamol trials recruiting patients?
Yes. 2 of the 5 trials are recruiting: 1 with sites in Canada and 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Salbutamol clinical trials?
University of British Columbia (2), China National Center for Cardiovascular Diseases (1), Medical University of Warsaw (1) and Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital (1). The number in brackets is how many trials each organisation leads.
Is Salbutamol licensed in Ireland?
Yes. The HPRA medicines list includes 13 single-substance products containing Salbutamol, for example Salamol CFC-Free Inhaler 100 micrograms pressurised inhalation, suspension (Norton Waterford). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
Is there a Salbutamol shortage?
The registers we track list 3 entries for Salbutamol: Salbutamol inhalation products (EU: shortage resolved); 2 German notices. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Salbutamol works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Salbutamol works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Salbutamol (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.